Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-21

Clinical Trial Update: A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection [Phase 2]

View source ↗

Summary

A Phase 2a study of IV BCV for adenovirus infection is currently recruiting, with cytomegalovirus infection also listed among the conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IV BCV

Snippet

Sponsor: SymBio Pharmaceuticals | Conditions: Adenovirus Infections, Cytomegalovirus Infection | Phase 2 | Status: RECRUITING